MSP-RON Pathway: Potential Regulator of Inflammation and Innate Immunity

25Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.

Abstract

Macrophage-stimulating protein (MSP), a soluble protein mainly synthesized by the liver, is the only known ligand for recepteur d'origine nantais (RON), which is a member of the MET proto-oncogene family. Recent studies show that the MSP-RON signaling pathway not only was important in tumor behavior but also participates in the occurrence or development of many immune system diseases. Activation of RON in macrophages results in the inhibition of nitric oxide synthesis as well as lipopolysaccharide (LPS)-induced inflammatory response. MSP-RON is also associated with chronic inflammatory responses, especially chronic liver inflammation, and might serve as a novel regulator of inflammation, which may affect the metabolism in the body. Another study provided evidence of the relationship between MSP-RON and autoimmune diseases, suggesting a potential role for MSP-RON in the development of drugs for autoimmune diseases. Moreover, MSP-RON plays an important role in maintaining the stability of the tissue microenvironment and contributes to immune escape in the tumor immune microenvironment. Here, we summarize the role of MSP-RON in immunity, based on recent findings, and lay the foundation for further research.

Cite

CITATION STYLE

APA

Huang, L., Fang, X., Shi, D., Yao, S., Wu, W., Fang, Q., & Yao, H. (2020, October 7). MSP-RON Pathway: Potential Regulator of Inflammation and Innate Immunity. Frontiers in Immunology. Frontiers Media S.A. https://doi.org/10.3389/fimmu.2020.569082

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free